Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Medico Remedies Ltd (MEDICO)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540937 NSE: MEDICO Pharmaceuticals & Drugs | Small Cap | Medico Remedies Share Price
₹33.90 -0.20 (-0.59%)
As on 22-Sep'26 12:11
Medico Remedies Ltd (MEDICO)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540937 NSE: MEDICO Pharmaceuticals & Drugs | Small Cap | Medico Remedies Share Price
₹33.90 -0.20 (-0.59%)
As on 22-Sep'26 12:11
Key Metrics
Valuation Multiples
Market Cap
₹283 Cr.
Current Price
₹33.9
52-Week Low / High
₹31 / 57
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
55.1
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
36.73%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
61.38%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹16.6 Cr.
Face Value
₹2
All Time Low / High
₹3.35 / 100.79
Check Before You Invest
Quality
Not GoodValuation
Somewhat UndervaluedCheck Valuation charts
Price Trend
Weak
Is Medico Remedies Ltd a good quality company?
Medico Remedies Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Medico Remedies Ltd performance compare with that of its Peers?
Revenue growth of Medico Remedies Ltd vs industry peers?
Medico Remedies Ltd revenue CAGR is %, compared to the industry median CAGR of 10.88%, indicating slower growth and losing its market share.
Promoter shareholding and pledge status of Medico Remedies Ltd?
Promoters hold 61.38% of the Medico Remedies Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Medico Remedies Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 21.6% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Medico Remedies Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 9.4% | 9.1% | 7.8% | 7.7% | 10.1% | 15.1% | 21.9% | 21.9% | 21.7% | 23.3% | - |
| Value Creation Index ⓘ | -0.3 | -0.4 | -0.4 | -0.5 | -0.3 | 0.1 | 0.6 | 0.6 | 0.6 | NA | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 54.4 | 61 | 97.7 | 88.6 | 122 | 121 | 140 | 145 | 151 | 206 | 238 |
| Sales YoY Gr. | - | 12.1% | 60.1% | -9.3% | 38.1% | -1.1% | 16.1% | 3.2% | 4.2% | 36.7% | - |
| Adj EPS ⓘ | 0.3 | 0.1 | 0.1 | 0.1 | 0.3 | 0.4 | 0.6 | 0.8 | 1 | 1.1 | 1.7 |
| YoY Gr. | - | -66.7% | 0% | -50% | 420% | 61.5% | 31% | 50.9% | 20.5% | 9% | - |
| BVPS (₹) ⓘ | 2.6 | 3.2 | 3.4 | 3.6 | 3.9 | 4.4 | 5.3 | 6.3 | 7.5 | 9.1 | 9.4 |
| Adj Net Profit ⓘ | 2 | 0.8 | 0.8 | 0.4 | 2.2 | 3.5 | 4.6 | 6.9 | 8.3 | 9.1 | 14 |
| Cash Flow from Ops. ⓘ | -3.2 | 5.1 | 4.9 | 1 | -11.3 | 5.9 | 8.2 | 2.4 | 4.9 | 5.9 | - |
| Debt/CF from Ops. ⓘ | -6 | 2.5 | 2.7 | 14.4 | -1.3 | 1.8 | 1 | 2.8 | 2.8 | 3.2 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 16% | 11% | 13.7% | 36.7% | ||||
| Adj EPS ⓘ | 15.4% | 33.2% | 25.6% | 9% | ||||
| BVPSⓘ | 15.1% | 18.4% | 19.9% | 20.9% | ||||
| Share Price | - | 21.4% | -21.7% | -21.4% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 12.5 | 3.7 | 3 | 1.5 | 6.9 | 10.1 | 11.3 | 14.3 | 14.4 | 13.1 | 18 |
| Op. Profit Mgn % ⓘ | 7.7 | 5.7 | 2.8 | 3.2 | 4.3 | 6.1 | 6.8 | 8.9 | 9.6 | 8.3 | 7.4 |
| Net Profit Mgn % ⓘ | 3.6 | 1.3 | 0.8 | 0.5 | 1.8 | 2.9 | 3.2 | 4.7 | 5.5 | 4.4 | 5.8 |
| Debt to Equity ⓘ | 1.2 | 0.5 | 0.5 | 0.5 | 0.5 | 0.3 | 0.2 | 0.1 | 0.2 | 0.3 | - |
| Working Cap Days ⓘ | 240 | 252 | 205 | 250 | 172 | 173 | 160 | 176 | 206 | 196 | 100 |
| Cash Conv. Cycle ⓘ | 81 | 83 | 50 | 57 | 41 | 51 | 56 | 64 | 95 | 92 | 39 |
Valuation of Medico Remedies - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Medico Remedies Ltd FAQs
The current trading price of Medico Remedies on 22-Sep-2026 12:11 is ₹33.90.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Sep-2026 the market cap of Medico Remedies stood at ₹283.0 Cr
The latest P/E ratio of Medico Remedies as of 21-Sep-2026 is 20.48.
The latest P/B ratio of Medico Remedies as of 21-Sep-2026 is 3.63.
The 52-week high of Medico Remedies is ₹56.99 and the 52-week low is ₹31.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medico Remedies is ₹238 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Medico Remedies Ltd is a below average quality company.
The key valuation ratios of Medico Remedies Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Medico Remedies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Medico Remedies Ltd
Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. Further in addition to the above, the company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, antihistaminic, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments.
The company was incorporated as Medico Remedies Private Limited on March 18, 1994 under the Companies Act, 1956 with the Registrar of Companies, Mumbai. The status of Company was changed to a public limited company and the name of Company was changed to Medico Remedies Limited by a special resolution passed on January 12, 2017. A fresh Certificate of Incorporation consequent upon conversion was issued on March 06, 2017 by the Registrar of Companies, Mumbai.
Business area of the company:
The company is engaged in manufacturing and selling of pharmaceutical formulation products in India.
Products
- Anti Biotics & Anti Infectives
- Beta-lactams- Penicillins
- Antifungals
- Miscellaneous
- Vitamins & Supplements
- Cardiovasculars
- Antipyretic, Analgesic, NSAIDs
- Antacid, Anti-Ulcer Drugs
- Antidepressants, Antipsychotics
- Antimalarials
- Dry Syrups
- Ointments & Creams
- Anti-Diabetics
- Syrups
Key Events and Milestones:
- 1994: Incorporated under Companies Act, 1956 as Medico Remedies Private Limited.
- 1999: Acquired plot at Palghar for setting up manufacturing set-up for general formulations.
- 2002: Acquired plot at Palghar for setting up manufacturing set-up for beta lactam.
- 2016: Renewed WHO-GMP Certification for their manufacturing facility.
- 2016: Purchased corporate premises at ‘Hubtown Solaris’.
- 2017: Renewed ISO-9001:2015 Certification for their manufacturing facility.
- 2017: Converted into a public limited company and the name of company was changed to Medico Remedies Ltd.
- 2023: Completed its trial production rounds at the newly established state of the art ointment manufacturing plant at Palghar.
- 2025: Secured government supply order worth around Rs 16.31 crore to supply to Dominican Republic (PROMESE/CAL).
- 2025: Commenced work for new factory for manufacturing of B lactum tablets, capsules, dry syrup and injections (including amoxycillin and clauvulinic acid formulations).
- 2025: Secured government supply order worth around $1.78 million from the Main Pharmacy Association of the Ministry of Health and Medical Industry of Turkmenistan.
- 2026: Secured government supply order worth around Rs 37.17 crore from Uttar Pradesh Medical Supplies Corporation.
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
